SC18-0393 Screening compound: N~4~-{[3-(1-acetyl-4-piperidyl)-1,2,4-oxadiazol-5-yl]methyl}-3-phenyl-1H-pyrazole-4-carboxamide

SC18-0393 Screening compound: N~4~-{[3-(1-acetyl-4-piperidyl)-1,2,4-oxadiazol-5-yl]methyl}-3-phenyl-1H-pyrazole-4-carboxamide
SC18-0393 Screening compound: N~4~-{[3-(1-acetyl-4-piperidyl)-1,2,4-oxadiazol-5-yl]methyl}-3-phenyl-1H-pyrazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound SC18-0393
N~4~-{[3-(1-acetyl-4-piperidyl)-1,2,4-oxadiazol-5-yl]methyl}-3-phenyl-1H-pyrazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SC18-0393

Molecular Formula

C20H22N6O3 (C20 H22 N6 O3)

Compound Name

N~4~-{[3-(1-acetyl-4-piperidyl)-1,2,4-oxadiazol-5-yl]methyl}-3-phenyl-1H-pyrazole-4-carboxamide

IUPAC name

N-{[3-(1-acetylpiperidin-4-yl)-124-oxadiazol-5-yl]methyl}-3-phenyl-1H-pyrazole-4-carboxamide

SMILES

CC(N(CC1)CCC1c1noc(CNC(c2c[nH]nc2-c2ccccc2)=O)n1)=O

InChI

InChI=1S/C20H22N6O3/c1-13(27)26-9-7-15(8-10-26)19-23-17(29-25-19)12-21-20(28)16-11-22-24-18(16)14-5-3-2-4-6-14/h2-6,11,15H,7-10,12H2,1H3,(H,21,28)(H,22,24)

InChI Key

KKTONHUZGSRNPG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD32256154

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

394.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.938

Distribution Coefficient, logD

1.938

Water Solubility, LogSw

-2.72

Polar Surface Area

97.572

Acid Dissociation Constant (pKa)

11.54

Base Dissociation Constant (pKb)

-0.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

SC18-0393 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with SC18-0393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SC18-0393?
Check Price and Availability of SC18-0393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SC18-0393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SC18-0393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SC18-0393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SC18-0393 available by request